TREATMENT COSTS | Marginal | Risk-factor | Universal | Savings |
---|---|---|---|---|
 | Unit costs | Screening | Screening |  |
Hospitalization | Â | Â | Â | Â |
Fatal and non-fatal anaphylaxis | 4,301 | 3,686 | 20,890 | Â |
Fatality vs. non-GBS | 1,997 | 2,347 | 968 | Â |
Sepsis vs. non GBS | 11,441 | 419,988 | 173,336 | Â |
Meningitis & sepsis vs. non-GBS | 14,710 | 59,998 | 24,762 | Â |
Post-Hospital Care vs. non-GBS | 2,130 | 89,393 | 36,894 | Â |
 |  | 575,412 | 256,851 | 318,561 |
LTC | Â | Â | Â | Â |
Deafness | 508,260 | 104,858 | 43,227 | Â |
Severe Neuro | 2,640,519 | 1,604,008 | 662,002 | Â |
Moderate Neuro | 1,281,790 | 828,425 | 341,906 | Â |
Mild Neuro | 316,180 | 216,369 | 89,299 | Â |
 |  | 2,753,659 | 908,003 | 1,617,175 |
Total Health Service Costs | Â | 2,775,870 | 1,136,483 | 1,935,737 |
Lifetime productivity losses | Â | 1,382,007 | 570,378 | 811,828 |
Total Societal Costs | Â | 4,711,077 | 1,963,713 | 2,747,365 |